Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Vocode | 2024 | Seed | $3.3M | San Francisco |
| Accent Therapeutics | 2024 | Series C | $75.0M | Lexington |
| Polar Signals | 2024 | Seed | $6.8M | Claymont |
| Comanche Biopharma | 2024 | Series B | $75.0M | Concord |
| Moonwalk Biosciences | 2024 | Series A | $57.0M | San Francisco |
| Tome Biosciences | 2023 | Series A | $213.0M | Watertown |
| Graft | 2023 | Seed | Undisclosed | San Francisco |
| Censys | 2023 | Series C | $50.0M | Ann Arbor |
| Signos | 2023 | Series B | $20.0M | Burlingame |
| ROME Therapeutics | 2023 | Series B | $72.0M | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | Vocode | Seed | $3.3M | San Francisco, United States |
| 152 | Accent Therapeutics | Series C | $75.0M | Lexington, United States |
| 153 | Polar Signals | Seed | $6.8M | Claymont, United States |
| 154 | Comanche Biopharma | Series B | $75.0M | Concord, United States |
| 155 | Moonwalk Biosciences | Series A | $57.0M | San Francisco, United States |
| 156 | Tome Biosciences | Series A | $213.0M | Watertown, United States |
| 157 | Graft | Seed | Undisclosed | San Francisco, United States |
| 158 | Censys | Series C | $50.0M | Ann Arbor, United States |
| 159 | Signos | Series B | $20.0M | Burlingame, United States |
| 160 | ROME Therapeutics | Series B | $72.0M | Cambridge, United States |
Vocode is an open-source library for building voice-based LLM applications.
Accent Therapeutics is a biopharmaceutical company.
Polar Signals is a profiling platform designed to measure and understand performance over time.
Our purpose is to make every pregnancy around the world safer.
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
Our Modern AI platform enables anyone to build production-ready AI apps in a few clicks.
Censys provides an internet intelligence platform for threat hunting and exposure management.
Signos pairs glucose data with an AI-enhanced app to bring visibility into metabolic function and guidance to drive health and weight loss.
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Context.ai is the product analytics platform for LLM applications. We help businesses understand user behaviour and product performance.
deepset offers the open-source AI Orchestration framework, Haystack, and a cloud and on-premise platform for enterprise AI teams.
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Speedy Brand provides generative AI-powered marketing content for SMBs.
Typeface offers a generative AI application that provides streamlined and personalized content creation for enterprises.
Caraway is providing college women+ with integrated mental, reproductive, and physical healthcare.
Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.
Guidelight Health creates an intensive outpatient and partial hospitalization program for clinical excellence.
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
OneNav provides a mobile positioning system intended for smartphones, wearables, and IoT tracking devices.
Urban Machine is a construction company that manufactures reclaims and co-creates locally sourced premium lumber products.
Air Protein develops protein-enriched food made from CO2.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
Kindbody is a fertility clinic network and family-building benefits provider for employers.
Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.
Google Ventures has invested in 303 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Google Ventures's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Medical, Pharmaceutical. The firm invests across 45 different industry categories.
Among tracked funding rounds, Tome Biosciences received $213.0M in a Series A round. Google Ventures's total known invested capital is $7.3B.
Google Ventures's average investment size is $34.6M across its portfolio of 303 companies.
Recent Google Ventures portfolio additions include Vocode, Accent Therapeutics, Polar Signals, Comanche Biopharma, Moonwalk Biosciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors